Shares of Synairgen plc (LON:SNG – Get Free Report) passed above its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of GBX 5.45 ($0.07) and traded as high as GBX 7.35 ($0.09). Synairgen shares last traded at GBX 7.02 ($0.09), with a volume of 30,405 shares changing hands.
Synairgen Price Performance
The company has a debt-to-equity ratio of 0.09, a current ratio of 6.77 and a quick ratio of 6.35. The stock has a market capitalization of £13.37 million, a P/E ratio of -140.40 and a beta of -2.23. The stock’s fifty day moving average is GBX 5.45 and its 200-day moving average is GBX 6.19.
Synairgen Company Profile
Synairgen plc discovers and develops drugs for respiratory diseases. It develops SNG001, an inhaled interferon beta for the treatment of COVID-19; inhaled interferon beta (IFN-ß), which is in Phase-II clinical trials for the treatment of asthma caused by the common cold and flu; and IFN-ß that is in Phase-II clinical trials for the treatment or prevention of chronic obstructive pulmonary disease.
Further Reading
- Five stocks we like better than Synairgen
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Charles Schwab Fortifies its Uptrend on EPS Beat
- How to Calculate Return on Investment (ROI)
- Lockheed Martin Stock Aims for a Fresh All-Time High
- How to Start Investing in Real Estate
- Beyond the Halving: The Future of Bitcoin Mining Stocks
Receive News & Ratings for Synairgen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synairgen and related companies with MarketBeat.com's FREE daily email newsletter.